IMARC Group has recently released a new research study titled “South Korea Digital Therapeutics Market Size, Share, Trends and Forecast by Application, End Use, and Region, 2025-2033”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios.
Market Overview
The South Korea digital therapeutics market size was USD 134.90 Million in 2024 and is forecasted to reach USD 737.78 Million by 2033, growing at a CAGR of 18.52% during 2025–2033. The market growth is driven by government initiatives promoting digital health innovation and the increasing burden of chronic and mental health disorders. The country's advanced digital infrastructure and high digital literacy support the adoption of digital therapeutics solutions.
Study Assumption Years
- Base Year: 2024
- Historical Year/Period: 2019-2024
- Forecast Year/Period: 2025-2033
South Korea Digital Therapeutics Market Key Takeaways
- Current Market Size (2024): USD 134.90 Million
- CAGR (2025-2033): 18.52%
- Forecast Period: 2025-2033
- The South Korean government is actively pushing digital health innovation through focused policies and strategic investments, including the Digital New Deal program.
- Regulatory bodies like the Ministry of Food and Drug Safety have introduced simplified approval mechanisms for digital therapeutics to accelerate market entry.
- The implementation of the Digital Medical Products Act (DMPA) in January 2024 facilitates regulation of AI-powered devices and digital health technologies.
- Increasing prevalence of chronic diseases (diabetes, hypertension, cardiovascular conditions) and mental health issues drives demand for scalable digital therapies.
- South Korea's high smartphone penetration, fast internet, and broad tech literacy enable accelerated adoption of digital therapeutics.
Sample Request Link: https://www.imarcgroup.com/south-korea-digital-therapeutics-market/requestsample
